Clearance of methotrexate by means of hemofiltration in a patient with osteosarcoma.
Escobosa Sánchez
O M
OM
Herrero Hernández
A
A
Ortega Acosta
M J
MJ
Camacho Alonso
J
J
Milano Manso
G
G
Acha García
T
T
D058186:Acute Kidney Injury / Q000139:chemically induced / Q000628:therapy*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000097:blood / Q000188:drug therapy*; D002648:Child; D002945:Cisplatin / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D006440:Hemofiltration; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics*; D012516:Osteosarcoma / Q000097:blood / Q000188:drug therapy*; D013977:Tibia; D011623:gamma-Glutamyl Hydrolase / Q000600:supply & distribution / Q000627:therapeutic use
D004317:Doxorubicin; D011623:gamma-Glutamyl Hydrolase; D002945:Cisplatin; D007069:Ifosfamide; D008727:Methotrexate